The patient presents to the emergency department with chest discomfort. You order a troponin. It comes back elevated. Acute myocardial infarction, right? Not necessarily.With the widespread adoption of high-sensitivity troponin (hs-Troponin) assays over the past few years, the landscape of cardiac biomarker interpretation has fundamentally changed. These newer assays detect troponin at levels 10 to 100 times lower than conventional assays, offering earlier detection of myocardial injury. But they’ve also introduced new challenges: more positive results, more diagnostic uncertainty, and more clinical dilemmas.This post will guide you through the practical interpretation of high-sensitivity troponin, help you distinguish acute coronary syndrome from other causes of troponin elevation, and equip you with strategies to use these powerful tools effectively without over diagnosing or undertreating.Why High-Sensitivity Troponin Changed EverythingHigh-sensitivity troponin assays were developed to detect myocardial injury earlier and with greater precision. The FDA approved several hs-Troponin assays for use in the United States starting in 2017, and by 2025, most major hospitals and emergency departments have transitioned to these platforms.The Advantage Hs-Troponin detects acute myocardial infarction earlier than conventional troponin, often within 1 to 3 hours of symptom onset rather than 6 to 12 hours. This enables faster diagnosis, earlier intervention, and potentially better outcomes. Studies show that hs-Troponin assays, combined with rapid rule-out protocols, can safely discharge low-risk patients from the emergency department within 1 to 3 hours, reducing unnecessary admissions and healthcare costs.The ChallengeHigher sensitivity means detecting troponin elevations that aren’t related to acute coronary syndrome. Chronic kidney disease, heart failure, myocarditis, pulmonary embolism, sepsis, and even strenuous exercise can elevate hs-Troponin.According to research published in Circulation, approximately 15 to 20% of patients presenting to emergency departments have detectable hs-Troponin levels, but only a fraction of these represents acute MI. The rest require clinical judgment to interpret correctly.Understanding the Difference: Acute vs. Chronic Troponin ElevationNot all troponin elevations are created equal. The key distinction is between acute myocardial injury and chronic elevation.Acute Myocardial InjuryCharacterized by: Rising or falling troponin pattern (delta change between serial measurements) Symptoms consistent with myocardial ischemia (chest pain, dyspnea, diaphoresis) ECG changes (ST elevation, ST depression, T-wave inversion, new Q waves) Acute clinical presentation Chronic Troponin Elevation Characterized by: Stable, persistently elevated troponin over time (minimal change between measurements) Absence of acute ischemic symptoms Known chronic conditions (CKD, heart failure, structural heart disease) No acute ECG changes The Fourth Universal Definition of Myocardial Infarction emphasizes that acute MI requires both an acute rise or fall in troponin and clinical evidence of myocardial ischemia. Elevated troponin alone is insufficient.Serial Troponin Measurements: The Data MattersSingle troponin values can be misleading. Serial measurements reveal the pattern. The 0/1 Hour Algorithm Many institutions now use accelerated diagnostic protocols: Baseline troponin at presentation (0 hour) Repeat troponin at 1 hour Interpretation: Rule-out threshold: If both values are below a very low threshold (specific to the assay, often 99% negative predictive value. Rule-in threshold: If either value exceeds the rule-in threshold (assay-specific, often >50-100 ng/L) AND there’s significant delta change (often >20% or >5-10 ng/L absolute change), acute MI is highly likely. Observation zone: Values between rule-out and rule-in thresholds require clinical judgment, additional testing, or extended observation. The 0/3 Hour Algorithm Some centers use 0 and 3-hour measurements. The principle is the same: look for dynamic change, not just absolute elevation. Why Delta Change MattersA troponin that rises from 15 ng/L to 80 ng/L over 1 to 3 hours suggests acute injury. A troponin that stays stable at 40 ng/L over the same period suggests chronic elevation.Dynamic change is the hallmark of acute MI.Common Non-ACS Causes of Elevated TroponinTroponin is highly sensitive for myocardial injury but not perfectly specific for acute coronary syndrome. Here are common alternative causes:Chronic Kidney DiseaseCKD is perhaps the most common cause of chronically elevated hs-Troponin. Reduced renal clearance and underlying cardiac structural changes (left ventricular hypertrophy, diastolic dysfunction) contribute.Patients with stage 4 or 5 CKD often have baseline troponin levels above the 99th percentile. Serial measurements and clinical correlation are essential.Acute and Chronic Heart FailureHeart failure causes myocardial stretching and wall stress, leading to troponin release. Both acute decompensation and chronic stable heart failure can elevate troponin.Distinguish from acute MI by assessing ischemic symptoms, ECG changes, and dynamic troponin patterns.Myocarditis and PericarditisInflammatory cardiac conditions elevate troponin. Myocarditis can present with chest pain, ECG changes, and troponin elevation that mimics MI.Clues to myocarditis include: Recent viral illness Younger patient without traditional cardiovascular risk factors Global or regional wall motion abnormalities on echocardiography not corresponding to coronary territories Cardiac MRI findings (late gadolinium enhancement) Pulmonary EmbolismAcute PE causes right ventricular strain and troponin elevation. Troponin positivity in PE correlates with worse outcomes and identifies higher-risk patients.Clinical presentation (dyspnea, pleuritic chest pain, hypoxia) and imaging (CT pulmonary angiography, elevated D-dimer) clarify the diagnosis.Sepsis and Critical IllnessSepsis, severe systemic illness, and shock can elevate troponin through: Supply-demand mismatch (hypotension, tachycardia reducing coronary perfusion) Inflammatory cytokines causing direct myocardial injury Microvascular dysfunction In septic patients, troponin elevation signals higher mortality risk but doesn’t necessarily indicate acute coronary occlusion.Takotsubo Cardiomyopathy (Stress-Induced Cardiomyopathy)Presents with chest pain, ECG changes, and troponin elevation following emotional or physical stress. Echocardiography shows apical ballooning with preserved basal function.Coronary angiography reveals no obstructive coronary disease. This is a diagnosis of exclusion but increasingly recognized.Strenuous ExerciseMarathon runners, ultra endurance athletes, and individuals engaging in extreme physical exertion can have transient troponin elevation. This typically resolves within 24 to 48 hours and is not associated with adverse outcomes.Chronic Structural Heart DiseaseSevere aortic stenosis, hypertrophic cardiomyopathy, and amyloidosis cause chronically elevated troponin due to ongoing myocardial stress and microinfarction.Integrating Troponin with Clinical AssessmentTroponin is a powerful tool, but it doesn’t replace clinical judgment. The diagnosis of acute MI requires integration of:Clinical Presentation Ischemic chest pain or equivalent symptoms (dyspnea, diaphoresis, nausea in elderly or diabetic patients) Risk factors (diabetes, hypertension, smoking, family history, hyperlipidemia) Onset and duration of symptoms ECG Findings ST-segment elevation or depression T-wave inversion New Q waves New left bundle branch block Serial Troponin Pattern Absolute level

You’ve seen it before. A patient’s lab results don’t match the clinical presentation. Two different tests contradict each other. The numbers look wrong, but you can’t immediately explain why.Discordant lab results are one of the most challenging scenarios in clinical practice. They create diagnostic uncertainty, delay treatment decisions, and can erode patient confidence. But here’s the truth: most discordant results aren’t lab errors. They’re opportunities to dig deeper and uncover what’s really happening.This post will walk you through a systematic approach to investigating discordant results, understanding their common causes, and making confident clinical decisions even when the data doesn’t initially align.Why Discordant Results Happen More Often Than You ThinkDiscordant laboratory results occur when test outcomes conflict with each other or don’t match the clinical picture. According to studies in clinical chemistry, pre-analytical errors account for approximately 60-70% of all laboratory mistakes, with sample quality issues, timing problems, and collection techniques being the primary culprits.But discordance isn’t always about error. Sometimes it’s biology. Hemoglobin variants can skew HbA1c results. Paraproteins interfere with routine chemistry panels. Lipemia affects sodium measurements. The list goes on.The challenge for clinicians is distinguishing between analytical interference, pre-analytical problems, and true pathophysiology that simply presents in an unexpected way.Common Scenarios Where Discordance AppearsGlucose and HbA1c MismatchA patient has a fasting glucose of 95 mg/dL but an HbA1c of 6.8%. Before assuming diabetes, consider hemoglobin variants (common in individuals of African, Mediterranean, or Southeast Asian descent), hemolytic anemia, or recent blood transfusions. These conditions alter red blood cell lifespan and affect HbA1c independently of glucose control.Sodium Discrepancy Between Lab and Point-of-Care TestingLab sodium reads 121 mmol/L. The point-of-care device shows 134 mmol/L. The patient appears clinically stable. Before treating severe hyponatremia, investigate sample integrity. Was there IV fluid contamination? Hemolysis? Lipemia or hyperproteinemia can cause pseudohyponatremia in indirect ion-selective electrode methods but not in direct methods.Elevated Alkaline Phosphatase with Normal Liver EnzymesAn isolated alkaline phosphatase elevation without accompanying ALT or AST elevation could indicate bone pathology, pregnancy, or benign familial hyperphosphatasemia rather than liver disease. Isoenzyme analysis or fractionation clarifies the source.Troponin Elevation Without Acute Coronary SyndromeTroponin is highly sensitive but not perfectly specific for myocardial infarction. Chronic kidney disease, myocarditis, pulmonary embolism, sepsis, and even extreme exercise can elevate troponin. Clinical correlation and serial measurements distinguish acute MI from other causes.A Systematic Approach to Investigating Discordant ResultsStep 1: Verify the Basics Before diving into complex explanations, confirm the fundamentals: Was the correct test ordered? Was the sample collected properly (right tube, right timing, right patient)? Did the sample reach the lab under appropriate conditions? Were there any flags or comments from the laboratory? Pre-analytical errors are shockingly common. A study published in Clinical Chemistry and Laboratory Medicine found that 46-68% of errors occur before the sample even reaches the analyzer.Step 2: Assess for Analytical InterferenceCertain substances interfere with laboratory assays: Hemolysis affects potassium, LDH, and AST measurements Lipemia interferes with spectrophotometric assays and can cause pseudohyponatremia Icterus affects bilirubin-sensitive assays Paraproteins (in multiple myeloma) interfere with protein assays and electrolyte measurements Biotin (high-dose supplementation) interferes with immunoassays that use biotin-streptavidin technology Most modern analyzers flag these interferences, but not all do. If results seem implausible, ask the lab to check for interference.Step 3: Consider Method-Specific DifferencesDifferent analyzers use different methodologies. Point-of-care devices, for instance, often use whole blood samples and different measurement principles than central laboratory analyzers.Sodium measurement is a classic example. Direct ion-selective electrodes (used in blood gas analyzers and some POCT devices) measure sodium activity in the water phase of plasma. Indirect methods (used in most chemistry analyzers) dilute the sample first, making them susceptible to pseudohyponatremia in the presence of high lipids or proteins. Understanding your laboratory’s methodology helps you interpret discrepancies intelligently. Step 4: Evaluate Timing and Biological VariationLaboratory values fluctuate. Cortisol varies by time of day. Postprandial glucose differs from fasting glucose. Creatinine changes with hydration status and muscle mass.If results seem discordant, consider: Was the sample collected at the appropriate time? Has the patient’s clinical status changed between tests? Are we comparing apples to oranges (fasting vs. non-fasting, morning vs. evening)? Biological variation is real. Reference intervals account for population variation, but individual patients can have significant day-to-day or hour-to-hour changes.Step 5: Communicate with the LaboratoryThis is perhaps the most underutilized step. Laboratory professionals are diagnostic partners, not just service providers. When results don’t make sense, call the lab.Ask: Were there any technical issues during analysis? Did the sample quality raise concerns? Would repeat testing on a fresh sample be helpful? Are there alternative methods or confirmatory tests available? Laboratory scientists often have insights that aren’t captured in the final report. Their input can be invaluable. When to Repeat Testing vs. When to Move Forward Not every discordant result requires repeat testing. Here’s how to decide: Repeat testing when: Pre-analytical error is suspected (hemolysis, contamination, timing issues) The result is critically abnormal and doesn’t match clinical presentation Analytical interference is possible The result would significantly alter management Move forward without repeating when: The discordance is explained by known biological variation Multiple consistent results support one interpretation over another The clinical picture is clear despite lab discordance Repeating the test won’t change management The key question is: will this information change what I do for this patient? If the answer is no, additional testing may not be warranted.Case Study: Resolving a Potassium Discrepancy A 62-year-old woman with chronic kidney disease presents for routine follow-up. Her labs show: Serum potassium: 6.2 mmol/L (critical high) No ECG changes Patient is asymptomatic Previous potassium levels have been in the 4.5-5.0 mmol/L range The initial impulse might be to treat hyperkalemia aggressively. But here’s what happened: Upon inquiry, the laboratory noted the sample was slightly hemolyzed. Hemolysis releases intracellular potassium into serum, falsely elevating the result. A repeat sample, collected carefully to avoid hemolysis, showed potassium of 4.8 mmol/L.No emergency treatment needed. No unnecessary hospitalization. Just good communication between clinician and laboratory.Building Confidence in Complex CasesDiscordant results test clinical judgment. They require you to balance